These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2627610

  • 1. Preliminary results of an induction combination regimen including fractionated anthracycline.
    Krieger O, Bernhart M, Fiedler E, Kasparu H, Weber E, Lutz D.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():66. PubMed ID: 2627610
    [No Abstract] [Full Text] [Related]

  • 2. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A].
    Beck JD.
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845
    [Abstract] [Full Text] [Related]

  • 3. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
    Carella AM, Pungolino E, Piatti G, Giordano D, Cerri R, Risso M, Nati S.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562
    [No Abstract] [Full Text] [Related]

  • 4. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
    Robak T, Krykowski E, Matusewicz W, Brodowski L, Hołub A, Drzewoski J.
    Pol Tyg Lek; 1988 Nov 21; 43(47):1508-11. PubMed ID: 3075284
    [No Abstract] [Full Text] [Related]

  • 5. Aclacinomycin, cytosine arabinoside and thioguanine in relapsed or resistant acute myeloid leukemia.
    Neri A, Comis M, Brugiatelli M, Martino B, Ronco F.
    Haematologica; 1989 Nov 21; 74(1):113-4. PubMed ID: 2498174
    [No Abstract] [Full Text] [Related]

  • 6. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I, Hara M, Ohmoto E, Oda Y, Endo Y, Fujimoto S, Uchida K, Takaoka K, Watanabe S, Lai M, Kohi F, Kitajima K, Kimura I, Sanada H, Tokioka M, Adachi T, Yorimitsu S.
    Gan To Kagaku Ryoho; 1982 Sep 21; 9(9):1617-22. PubMed ID: 6964050
    [Abstract] [Full Text] [Related]

  • 7. ["AB-Triple V" therapy of relapsed or refractory acute myelogenous leukemia].
    Asou N, Suzushima H, Hamasaki N, Goto J, Hidaka M, Akagi K, Kurisaki H, Sawatari T, Kawano F, Takatsuki K.
    Rinsho Ketsueki; 1989 Feb 21; 30(2):169-74. PubMed ID: 2746873
    [Abstract] [Full Text] [Related]

  • 8. Treatment of refractory acute leukaemia with aclacinomycin A.
    Rowe JM, Chang AY, Bennett JM.
    Bone Marrow Transplant; 1989 Dec 21; 4 Suppl 3():47-8. PubMed ID: 2627607
    [No Abstract] [Full Text] [Related]

  • 9. Acute adult leukemia. The Danbury Hospital experience.
    Provatas AC, Pezzimenti J, Cooper RB.
    Conn Med; 1988 Sep 21; 52(9):515-7. PubMed ID: 3180801
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Candoni A, Simeone E, Tiribelli M, Malagola M, Russo D, Fanin R.
    Am J Hematol; 2009 Oct 21; 84(10):690-2. PubMed ID: 19731308
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic effect of priming induction regimen of CAG for newly diagnosed acute myeloid leukemia in elderly patients].
    Chen YJ, Zhang LQ, Li XL, Zhao XL, Wu DS, Shu YG, Chen FP.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar 21; 33(3):245-51. PubMed ID: 18382060
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia].
    Saito K, Furusawa S, Yamada K, Waga K, Aoyagi A, Koike T, Arimura H, Noguchi M, Yamato H, Sakuma H.
    Rinsho Ketsueki; 1995 Mar 21; 36(3):165-74. PubMed ID: 7540220
    [Abstract] [Full Text] [Related]

  • 14. Acute myeloblastic leukemia in adults.
    Kasthuri AS, Jaiprakash MP, Anand KP, Kumar R.
    J Assoc Physicians India; 1995 Feb 21; 43(2):108-10. PubMed ID: 9282674
    [No Abstract] [Full Text] [Related]

  • 15. Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia.
    Fink FM, Grümayer ER, Kardos G, Revesz T, Gadner H, Schuler D.
    Haematol Blood Transfus; 1987 Feb 21; 30():393-8. PubMed ID: 3305209
    [No Abstract] [Full Text] [Related]

  • 16. Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.
    Bow EJ, Gallant G, Williams GJ, Woloschuk D, Shore TB, Rubinger M, Schacter BA.
    Cancer; 1998 Oct 01; 83(7):1344-54. PubMed ID: 9762935
    [Abstract] [Full Text] [Related]

  • 17. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F, Fernández-Barbieri MA, Santarelli MT, Matus-Ridley M, Rosso A, Negri-Aranguren P, Cerutti I, Gomel M, Kvicala R.
    Semin Oncol; 1993 Dec 01; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [Abstract] [Full Text] [Related]

  • 18. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS, Aoki FY, Bow EJ.
    J Clin Pharmacol; 2008 Aug 01; 48(8):995-8. PubMed ID: 18495946
    [No Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
    Lou FD, Zhou Q, Liu HC, Meng FY, Wang YZ.
    Chin Med J (Engl); 1993 Nov 01; 106(11):876-8. PubMed ID: 8143502
    [No Abstract] [Full Text] [Related]

  • 20. ["A-triple-V" in refractory or relapsed acute myelocytic leukemia].
    Miyawaki S, Nemoto K, Wakamatsu R, Baba N, Yashiro K, Uchida S, Nakura M, Karasawa M, Takada M, Tanaka H.
    Rinsho Ketsueki; 1987 Jan 01; 28(1):34-9. PubMed ID: 3471982
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.